REG - Inspiration Health - Board Change

Inspiration HealthcareAnnouncement

14/11/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241114:nRSN1686Ma&default-theme=true

RNS Number : 1686M  Inspiration Healthcare Group PLC  14 November 2024

14 November 2024

 

The information contained within this announcement is deemed by the Company to
constitute inside information stipulated under the Market Abuse Regulation
(EU) No. 596/2014 as amended by the Market Abuse (Amendment) (EU Exit)
Regulations 2019. Upon the publication of this announcement via the Regulatory
Information Service, this inside information is now considered to be in the
public domain.

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Board Changes

 

Inspiration Healthcare Group plc (AIM: IHC) ("Inspiration Healthcare" or the
"Company"), the global medical technology company, today announces that Mr
Brook Nolson will step down from the role of Chief Operating Officer with
immediate effect to pursue other opportunities.

 

The Board would like to thank Brook for his hard work and dedication to the
company over the past 12 years and wish him every success in his future
endeavours.

 

For further information, please contact:

 

 Inspiration Healthcare Group plc                                                  Tel: +44 (0)330
                                                   175 0000
 Roy Davis, Executive Chairman

 Alan Olby, Chief Financial Officer

 Panmure Liberum (Nominated Adviser & Broker)                                      Tel: +44 (0)20
                                                   3100 2000
 Richard Lindley

 Will King

 Walbrook PR Ltd (Media and Investor Relations)    Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
 Anna Dunphy                                       Mob: +44 (0) 7876 741 001
 Louis Ashe-Jepson                                 Mob: +44 (0) 7747 515 393

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets
pioneering medical technology. Based in the UK, the Company specialises in
neonatal intensive care medical devices, which are addressing a critical need
to help to save the lives and improve the outcomes of patients, starting with
the very first breaths of life.

 

The Company has a broad portfolio of its own products and complementary
distributed products, for use in neonatal intensive care designed to support
even the most premature babies throughout their hospital stay. Its own branded
products range from highly sophisticated capital equipment such as ventilators
for life support through to single-use disposables.

 

The Company sells its products directly to hospitals and healthcare providers
in the UK and Ireland, where it also distributes a range of advanced medical
technologies for infusion therapy.  In the rest of the world the Company has
an established network of distribution partners around the world giving access
to more than 75 countries.

 

The Company operates in the UK from its world-class Manufacturing and
Technology Centre in Croydon, South London and in the USA from its facility in
Melbourne, Florida.

 

Further information on Inspiration Healthcare can be found
at www.inspirationhealthcaregroup.com
(http://www.inspirationhealthcaregroup.com)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOABJBBTMTMBTLI